Michèle Schulz

Michèle Schulz is a Regulatory CMC Strategist specializing in cell and gene therapies at Bayer AG, where they previously held roles as a Business Excellence Manager and Regulatory CMC Manager for biotech products. Their extensive experience in regulatory affairs includes consulting and project management at Xendo and IT project management at Bayer Business Services. Michèle earned a PhD in Chemistry from the University of York and holds a Diplom in Biophysics from Humboldt-Universität zu Berlin. Throughout their career, they have demonstrated excellent communication and analytical skills while contributing to cross-functional and global teams.